Composition, form of production and packaging
? Spray nasal dosed as a colorless, transparent solution, odorless.
30 ml
sea ​​water with natural microelements 9 ml,
in t.ch. Na + not less than 2500 mg / l
Ca 2+ not less than 80 mg / l
Mg 2+ not less than 350 mg / l
Cl - not less than 5500 mg / l
SO 4 2- not less than 600 mg / l
HCO 3 - not less than 30 mg / l
Excipients: purified water.
30 ml (30.36 g) - bottles of dark glass (1) with a dispensing device, a spray head and a protective cover - packs of cardboard.
? Nasal drops for children are colorless, transparent, odorless.
10 ml
sea ​​water with natural microelements 3 ml,
in t.ch. Na + not less than 2500 mg / l
Ca 2+ not less than 80 mg / l
Mg 2+ not less than 350 mg / l
Cl - not less than 5500 mg / l
SO 4 2- not less than 600 mg / l
HCO 3 - not less than 30 mg / l
Excipients: purified water.
10 ml - a bottle-droppers polyethylene (1) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2012.
PHARMACHOLOGIC EFFECT
A preparation of natural origin for topical application, the effect of which is determined by the properties of the components that make up its composition.
Sea water, sterilized and reduced to an isotonic state, helps maintain the normal physiological state of the mucous membrane of the nasal cavity.
The drug promotes the liquefaction of mucus and the normalization of its production in goblet cells of the mucous membrane.
Microelements included in the preparation improve the function of the ciliated epithelium.
The drug promotes washing and removal of street and room dust, allergens and hapten from the nasal mucosa, reducing the local inflammatory process.
PHARMACOKINETICS
Data on the pharmacokinetics of Aqua Maris is not available.
INDICATIONS
- acute and chronic inflammatory diseases of the nasal cavity, paranasal sinuses and nasopharynx;
- adenoiditis;
- Postoperative period after surgical interventions on the nasal cavity;
- allergic and vasomotor rhinitis (especially in people with increased sensitivity to medicines or with a predisposition to it, including during pregnancy and lactation);
- prevention and treatment (as part of complex therapy) of infections of the nasal cavity in the autumn and winter period (including during pregnancy and lactation);
- dryness of the mucous membrane of the nasal cavity; preservation of physiological characteristics of the mucous membrane of the nasal cavity in altered microclimatic conditions - in people living and working in air-conditioned rooms and / or central heating, in people whose mucous membranes of the upper respiratory tract are constantly exposed to harmful effects (for smokers, drivers of vehicles , people working in hot and dusty shops, living in regions with harsh climatic conditions).
DOSING MODE
For the treatment of Aqua Maris, nasal drops for children can be administered to children from the 1st day of life to 2 drops in each nasal passage 4 times / day.Aqua Maris spray nasal dosed prescribed for children aged 1 to 7 years for 2 injections in each nostril 4 times / day; children aged 7 to 16 years - 2 injections in each nostril 4-6 times / day, adults - 2-3 injections in each nasal passage 4-8 times / day. The duration of the course of therapy is 2-4 weeks. It is recommended to repeat the course in a month.
For prevention it is recommended to use the toilet in the form of instillation Aqua Maris drops nasal for children from the 1st day of life 2-3 times / day 1-2 drops in each nasal passage. Aqua Maris nasal spray dosage is used in children aged 1 year to 7 years , 1-2 injections in each nasal passage 2-3 times / day; children aged 7 to 16 years - 2 injections in each nasal passage 2-4 times / day, adults - 2-3 injections in each nasal passage 3-6 times / day.
To soften and remove contaminant accumulations and nasal excretions, Aqua Maris is injected or buried in each nasal passage as much as the situation requires, eliminating excess fluid with cotton wool or a handkerchief. The procedure can be repeated many times until the clusters of contaminants are successfully softened or removed.
SIDE EFFECT
Possible: allergic reactions.
CONTRAINDICATIONS
- Children under 1 year of age (for nasal dosed spray);
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
It is possible to use the drug Aqua Maris during pregnancy and lactation (breastfeeding) according to the indications.
APPLICATION FOR CHILDREN
It should be noted that children under 1 year of age is a contraindication for a nasal dosed spray.
For the treatment of Aqua Maris, nasal drops for children can be administered to children from the 1st day of life to 2 drops in each nasal passage 4 times / day.Aqua Maris spray nasal dosed prescribed for children aged 1 to 7 years for 2 injections in each nostril 4 times / day; children aged 7 to 16 years - 2 injections per each nasal stroke 4-6 times / day. The duration of the course of therapy is 2-4 weeks. It is recommended to repeat the course in a month.
For prevention it is recommended to use the toilet in the form of instillation Aqua Maris drops nasal for children from the 1st day of life 2-3 times / day 1-2 drops in each nasal passage. Aqua Maris nasal spray dosage is used in children aged 1 year to 7 years , 1-2 injections in each nasal passage 2-3 times / day; children aged 7 to 16 years - 2 injections in each nasal passage 2-4 times / day.
SPECIAL INSTRUCTIONS
Newborn solution should be instilled in the nasal cavity with caution, with a minimum pressure on the bottle (due to the risk of infection of the middle ear).
The simultaneous use of other drugs in the treatment of rhinitis.
OVERDOSE
To date, no cases of an overdose of Aqua Maris have been reported.
DRUG INTERACTION
Drug interaction of the drug Aqua Maris was not observed.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of the reach of children at a temperature of no higher than 25 В° C. Shelf life of nasal spray - 3 years, drops of nasal - 2 years.
The contents of the vial are sterile. After opening the vial, the drug should be used within 45 days.
